Mabthera and septic shock Patient Reports February 12, 2012
Mabthera Side Effects Report #5649809-7
Mabthera side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Feb 21, 2008. Female patient, 68 years of age, was diagnosed with vasculitis
, cryoglobulinaemia and was treated with Mabthera. After drug was administered, patient experienced the following side effects: confusional state, haemorrhage intracranial, pericardial effusion, pleural effusion, pyrexia, respiratory distress, respiratory failure, septic shock, thrombocytopenia. Mabthera dosage: 500 MG, UNK. During the same period patient was treated with CYCLOPHOSPHAMIDE, HYDROCORTISONE, LORATADINE, ACAMOL, PREDNISONE, CARBAMAZEPINE, ALFACALCIDOL, CALCIMORE. Patient was hospitalized. Patient died on 02/17/2008.Mabthera Side Effects Report #5315012-3
Mabthera side effect was reported by a Physician from FRANCE on Apr 24, 2007. Female patient, 60 years of age, was diagnosed with rheumatoid arthritis
and was treated with Mabthera. After drug was administered, patient experienced the following side effects: septic shock, small intestinal perforation. Mabthera dosage: unknown. During the same period patient was treated with CORTICOSTEROID NOS. Patient died.Mabthera Side Effects Report #5392225-6
Mabthera side effect was reported by a Physician from FRANCE on July 12, 2007. Female patient was diagnosed with rheumatoid arthritis
and was treated with Mabthera. After drug was administered, patient experienced the following side effects: cholangitis, multi-organ failure, peritonitis, septic shock, small intestinal perforation. Mabthera dosage: unknown. During the same period patient was treated with CHRONO, CORTANCYL, RIVOTRIL, ARAVA, ANAFRANIL, DAFALGAN CODEINE, NEXIUM. Patient died on 04/13/2007.Mabthera Side Effects Report #5872905-6
Mabthera side effect was reported by a Health Professional from NORWAY on Aug 25, 2008. Female patient was diagnosed with rheumatoid arthritis
, anaemia of chronic disease and was treated with Mabthera. After drug was administered, patient experienced the following side effects: pneumonia
, septic shock. Mabthera dosage: 1000 MG, Q2W. During the same period patient was treated with MIRCERA, PREDNISOLONE, LISINOPRIL, LEVOTHYROXINE, NEXIUM, CALCIUM CARBONATE, VITAMIN D. Patient was hospitalized. Patient died on 08/03/2008.Mabthera Side Effects Report #5904000-1
Mabthera side effect was reported by a Health Professional from NORWAY on Sept 16, 2008. Female patient was diagnosed with rheumatoid arthritis
, anaemia of chronic disease and was treated with Mabthera. After drug was administered, patient experienced the following side effects: pneumonia
, septic shock. Mabthera dosage: 1000 MG, Q2W. During the same period patient was treated with MIRCERA, PREDNISOLONE, LISINOPRIL, LEVOTHYROXINE, NEXIUM, CALCIUM CARBONATE, VITAMIN D. Patient was hospitalized. Patient died on 08/03/2008.Mabthera Side Effects Report #5906689-X
Mabthera side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Sept 22, 2008. Female patient was diagnosed with rheumatoid arthritis
and was treated with Mabthera. After drug was administered, patient experienced the following side effects: pleural effusion, pneumonia
, septic shock. Mabthera dosage: unknown. During the same period patient was treated with PREDNISOLONE, OXYCONTIN, ALENDRONATE, CALCICHEW. Patient was hospitalized. Patient recovered.Mabthera Side Effects Report #6087987-9
Mabthera side effect was reported by a Physician from FRANCE on Feb 10, 2009. Female patient, 47 years of age, was diagnosed with pemphigus
and was treated with Mabthera. After drug was administered, patient experienced the following side effects: renal amyloidosis, septic shock. Mabthera dosage: 375 MG/M2, 1/WEEK. During the same period patient was treated with CYCLOPHOSPHAMIDE, COLCHICINE, PREDNISONE. Patient died.Mabthera Side Effects Report #5595008-7
Mabthera side effect was reported by a Physician from JAPAN on Jan 09, 2008. Female patient, 76 years of age, weighting 97.66 lb, was diagnosed with non-hodgkin's lymphoma and was treated with Mabthera. After drug was administered, patient experienced the following side effects: platelet count decreased, pneumonia
, septic shock, urinary tract infection
, white blood cell count decreased. Mabthera dosage: 530 MG, UNK. During the same period patient was treated with IFOSFAMIDE, CISPLATIN, ETOPOSIDE. Patient died on 04/28/2007.Mabthera Side Effects Report #5632647-9
Mabthera side effect was reported by a Physician from JAPAN on Feb 12, 2008. Female patient, 76 years of age, weighting 97.66 lb, was diagnosed with non-hodgkin's lymphoma and was treated with Mabthera. After drug was administered, patient experienced the following side effects: platelet count decreased, pneumonia
, septic shock, urinary tract infection
, white blood cell count decreased. Mabthera dosage: 530 MG, UNK. During the same period patient was treated with IFOSFAMIDE, CISPLATIN, ETOPOSIDE, MANNITOL. Patient died on 04/28/2007.Mabthera Side Effects Report #4819041-5
Mabthera side effect was reported by a Health Professional from POLAND on Oct 17, 2005. Male patient, 70 years of age, was diagnosed with non-hodgkin's lymphoma and was treated with Mabthera. After drug was administered, patient experienced the following side effects: blood albumin increased, blood creatinine increased, haemoglobin decreased, ileus paralytic, large intestinal obstruction, platelet count decreased, pneumonia
, septic shock, white blood cell count decreased. Mabthera dosage: 700 MG, QD, INTRAVENOUS. During the same period patient was treated with CYCLOPHOSPHAMIDE, VINCRISTINE, ADRIAMYCIN PFS, PREDNISONE. Patient was hospitalized and became disabled. Patient recovered.Mabthera Side Effects Report #4825018-6
Mabthera side effect was reported by a Health Professional from POLAND on Oct 27, 2005. Male patient, 70 years of age, was diagnosed with non-hodgkin's lymphoma and was treated with Mabthera. After drug was administered, patient experienced the following side effects: blood albumin increased, blood creatinine increased, haemoglobin decreased, ileus paralytic, platelet count decreased, pneumonia
, septic shock. Mabthera dosage: 700 MG, QD, INTRAVENOUS. During the same period patient was treated with CYCLOPHOSPHAMIDE, VINCRISTINE, ADRIAMYCIN PFS, PREDNISONE. Patient was hospitalized and became disabled. Patient recovered.Mabthera Side Effects Report #4692213-9
Mabthera side effect was reported by a Health Professional from on June 02, 2005. Female patient, 82 years of age, was diagnosed with lymphoma
and was treated with Mabthera. After drug was administered, patient experienced the following side effects: aplastic anaemia, bone marrow depression, septic shock. Mabthera dosage: unknown. During the same period patient was treated with CYCLOPHOSPHAMIDE, FLUDARABINE PHOSPHATE. Patient died on 02/14/2005.Mabthera Side Effects Report #4784839-9
Mabthera side effect was reported by a Health Professional from SWEDEN on Sept 15, 2005. Female patient, 82 years of age, was diagnosed with lymphoma
and was treated with Mabthera. After drug was administered, patient experienced the following side effects: aplastic anaemia, bone marrow depression, septic shock. Mabthera dosage: 700 MG, INTRAVENOUS. During the same period patient was treated with CYCLOPHOSPHAMIDE, FLUDARA, PLENDIL, DIFLUCAN, OMEPRAZOLE, TRIMETHOPRIM, AZACTAM, VANCOMYCIN. Patient died on 04/17/2005.Mabthera Side Effects Report #5912907-4
Mabthera side effect was reported by a Physician from TAIWAN, PROVINCE OF CHINA on Sept 29, 2008. Female patient, 73 years of age, was diagnosed with lymphoma
and was treated with Mabthera. After drug was administered, patient experienced the following side effects: cardiac arrest
, septic shock. Mabthera dosage: 375 MG/KG, UNK. During the same period patient was treated with PREDNISOLONE, VINCRISTINE. Patient died.Mabthera Side Effects Report #5030843-5
Mabthera side effect was reported by a Physician from SPAIN on June 08, 2006. Female patient, 66 years of age, was diagnosed with lymphoma
and was treated with Mabthera. After drug was administered, patient experienced the following side effects: hepatitis toxic, hepatotoxicity, pseudomonal sepsis, respiratory failure, septic shock. Mabthera dosage: 375 MG/M2, Q2M, INTRAVENOUS. During the same period patient was treated with PREDNISONE, CITALOPRAM, LORAZEPAM. Patient died on 07/11/2002.Mabthera Side Effects Report #6089560-5
Mabthera side effect was reported by a Physician from UNITED KINGDOM on Feb 09, 2009. Male patient, 21 years of age, was diagnosed with idiopathic thrombocytopenic purpura, colitis and was treated with Mabthera. After drug was administered, patient experienced the following side effects: septic shock. Mabthera dosage: 700 MG, 1/WEEK. During the same period patient was treated with IMUREL, CORTANCYL, REMICADE. Patient was hospitalized. Patient died.
Mabthera Side Effects Report #5718575-9
Mabthera side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Apr 15, 2008. Male patient, weighting 165.3 lb, was diagnosed with idiopathic thrombocytopenic purpura and was treated with Mabthera. After drug was administered, patient experienced the following side effects: catheter related infection, iiird nerve disorder, miller fisher syndrome, septic shock, vith nerve paralysis. Mabthera dosage: 375 MG/M2, 1/WEEK. During the same period patient was treated with SINTROM, BETA BLOCKER NOS. Patient recovered.
Mabthera Side Effects Report #5979625-8
Mabthera side effect was reported by a Physician from UNITED KINGDOM on Nov 21, 2008. Male patient was diagnosed with idiopathic thrombocytopenic purpura and was treated with Mabthera. After drug was administered, patient experienced the following side effects: cholestasis, hepatic failure, hepatic function abnormal, multi-organ failure, neutropenia, pneumonia
, septic shock. Mabthera dosage: unknown. During the same period patient was treated with PREDNISOLONE, PANTOPRAZOLE, MAGNOSOLV. Patient died on 06/17/2008.Mabthera Side Effects Report #4644290-9
Mabthera side effect was reported by a Physician from on Apr 13, 2005. Male patient, 79 years of age, weighting 152.1 lb, was diagnosed with diffuse large b-cell lymphoma and was treated with Mabthera. After drug was administered, patient experienced the following side effects: agranulocytosis, blood lactate dehydrogenase increased, c-reactive protein increased, haemoglobin decreased, platelet count decreased, pneumonia
, respiratory failure, septic shock, ventricular fibrillation. Mabthera dosage: 375 MG/M2. During the same period patient was treated with CYCLOPHOSPHAMIDE, DOXORUBICIN HYDROCHLORIDE, VINCRISTINE, PREDNISONE, ETOPOSIDE, DISALUNIL, BISOPROLOL, OMNIC. Patient was hospitalized. Patient died on 03/28/2005.Mabthera Side Effects Report #4661220-4
Mabthera side effect was reported by a Physician from on May 09, 2005. Male patient, 79 years of age, weighting 152.1 lb, was diagnosed with diffuse large b-cell lymphoma and was treated with Mabthera. After drug was administered, patient experienced the following side effects: agranulocytosis, haemoglobin decreased, platelet count decreased, pneumonia
, respiratory failure, septic shock, ventricular fibrillation. Mabthera dosage: 375 MG/M2. During the same period patient was treated with CYCLOPHOSPHAMIDE, DOXORUBICIN HYDROCHLORIDE, VINCRISTINE, PREDNISONE, ETOPOSIDE, DISALUNIL, BISOPROLOL, OMNIC. Patient was hospitalized. Patient died on 03/28/2005.Mabthera Side Effects Report #4629459-1
Mabthera side effect was reported by a Physician from on Mar 23, 2005. Male patient, 76 years of age, was diagnosed with diffuse large b-cell lymphoma and was treated with Mabthera. After drug was administered, patient experienced the following side effects: agranulocytosis, cough, haemoglobin decreased, platelet count decreased, pneumonia
, respiratory failure, septic shock, ventricular fibrillation. Mabthera dosage: 375 MG/M2. During the same period patient was treated with CYCLOPHOSPHAMIDE, DOXORUBICIN HYDROCHLORIDE, VINCRISTINE, PREDNISONE, DISALUNIL, BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE, TAMSULOSIN, ATORVASTATIN. Patient was hospitalized. Patient recovered.Mabthera Side Effects Report #4633269-9
Mabthera side effect was reported by a Health Professional from on Apr 05, 2005. Male patient, 76 years of age, was diagnosed with diffuse large b-cell lymphoma and was treated with Mabthera. After drug was administered, patient experienced the following side effects: agranulocytosis, blood lactate dehydrogenase increased, c-reactive protein increased, haemoglobin decreased, platelet count decreased, pneumonia
, respiratory failure, septic shock, ventricular fibrillation. Mabthera dosage: 375 MG/M2. During the same period patient was treated with CYCLOPHOSPHAMIDE, DOXORUBICIN HYDROCHLORIDE, VINCRISTINE, PREDNISONE, DISALUNIL, BISOPROLOL, TAMSULOSIN, ATORVASTATIN. Patient was hospitalized. Patient died.Mabthera Side Effects Report #4842205-1
Mabthera side effect was reported by a Physician from GERMANY on Nov 15, 2005. Male patient, 67 years of age, was diagnosed with diffuse large b-cell lymphoma and was treated with Mabthera. After drug was administered, patient experienced the following side effects: bacterial sepsis, septic shock. Mabthera dosage: 500 MG. During the same period patient was treated with CYCLOPHOSPHAMIDE, VINCRISTINE, DOXORUBICIN, PREDNISONE. Patient died on 03/02/2004.
Mabthera Side Effects Report #5281330-0
Mabthera side effect was reported by a Physician from SWITZERLAND on Mar 14, 2007. Male patient, 64 years of age, was diagnosed with diffuse large b-cell lymphoma and was treated with Mabthera. After drug was administered, patient experienced the following side effects: febrile neutropenia, haematotoxicity, haemoglobin decreased, multi-organ failure, platelet count decreased, septic shock, white blood cell count decreased. Mabthera dosage: 700 MG. During the same period patient was treated with IFOSFAMIDE, CARBOPLATIN, ETOPOSIDE. Patient was hospitalized. Patient died on 09/01/2005.
Mabthera Side Effects Report #4776604-3
Mabthera side effect was reported by a Health Professional from SWITZERLAND on Sept 05, 2005. Male patient, 64 years of age, was diagnosed with diffuse large b-cell lymphoma and was treated with Mabthera. After drug was administered, patient experienced the following side effects: febrile neutropenia, haematotoxicity, haemoglobin decreased, infection
, laboratory test interference, septic shock, white blood cell count decreased. Mabthera dosage: unknown. During the same period patient was treated with IFOSFAMIDE, CARBOPLATIN, ETOPOSIDE. Patient was hospitalized. Patient recovered.Mabthera Side Effects Report #5046571-6
Mabthera side effect was reported by a Physician from ITALY on June 08, 2006. Female patient was diagnosed with diffuse large b-cell lymphoma and was treated with Mabthera. After drug was administered, patient experienced the following side effects: adverse event, septic shock. Mabthera dosage: 375 MG/M2. During the same period patient was treated with DOXORUBICIN, VINCRISTINE, CYCLOPHOSPHAMIDE, PREDNISONE, NEULASTA. Patient died.
Mabthera Side Effects Report #5981876-3
Mabthera side effect was reported by a Physician from UNITED KINGDOM on Nov 24, 2008. Male patient was diagnosed with connective tissue disorder
and was treated with Mabthera. After drug was administered, patient experienced the following side effects: cerebral toxoplasmosis, fall
, septic shock, status epilepticus. Mabthera dosage: 1000 MG, UNK. During the same period patient was treated with PREDNISONE, METHOTREXATE, IDEOS, COVERSYL, PREVISCAN. Patient was hospitalized. Patient died on 09/16/2008.Mabthera Side Effects Report #6049405-6
Mabthera side effect was reported by a Physician from UNITED KINGDOM on Jan 08, 2009. Male patient was diagnosed with connective tissue disorder
and was treated with Mabthera. After drug was administered, patient experienced the following side effects: septic shock, status epilepticus, toxoplasmosis. Mabthera dosage: 1000 MG, UNK. During the same period patient was treated with PREDNISONE, METHOTREXATE, IDEOS, COVERSYL, PREVISCAN. Patient was hospitalized. Patient died on 09/16/2008.Mabthera Side Effects Report #4989031-0
Mabthera side effect was reported by a Health Professional from BELGIUM on Apr 11, 2006. Male patient, 58 years of age, weighting 183.0 lb, was diagnosed with chronic lymphocytic leukaemia and was treated with Mabthera. After drug was administered, patient experienced the following side effects: acute respiratory distress syndrome, disseminated intravascular coagulation, renal failure acute, septic shock. Mabthera dosage: 750 MG, INTRAVENOUS. During the same period patient was treated with CYCLOPHOSPHAMIDE, FLUDARABINE, AVELOX, ZOVIRAX. Patient died on 04/09/2006.
Mabthera Side Effects Report #4992483-3
Mabthera side effect was reported by a Physician from BELGIUM on Apr 19, 2006. Male patient, 58 years of age, weighting 183.0 lb, was diagnosed with chronic lymphocytic leukaemia and was treated with Mabthera. After drug was administered, patient experienced the following side effects: acute respiratory distress syndrome, bronchopneumonia, disseminated intravascular coagulation, renal failure acute, septic shock. Mabthera dosage: 750 MG, UNK, INTRAVENOUS. During the same period patient was treated with CYCLOPHOSPHAMIDE, FLUDARABINE, AVELOX, ZOVIRAX. Patient died on 04/09/2006.
Mabthera Side Effects Report #6134180-7
Mabthera side effect was reported by a Health Professional from UNITED KINGDOM on Mar 18, 2009. Female patient was diagnosed with chronic lymphocytic leukaemia and was treated with Mabthera. After drug was administered, patient experienced the following side effects: septic shock. Mabthera dosage: 375 MG/M2, Q3W. During the same period patient was treated with IFOSFAMIDE, ETOPOSIDE, VINCRISTINE, DEXAMETHASONE, EPIRUBICIN, CARBOPLATIN, CYCLOPHOSPHAMIDE. Patient died.
Mabthera Side Effects Report #5377788-9
Mabthera side effect was reported by a Physician from FRANCE on June 26, 2007. Male patient, 62 years of age, was diagnosed with chondritis and was treated with Mabthera. After drug was administered, patient experienced the following side effects: influenza, septic shock. Mabthera dosage: 375 MG/M2, UNK. During the same period patient was treated with CORTICOSTEROID. Patient was hospitalized. Patient died.
Mabthera Side Effects Report #5388655-9
Mabthera side effect was reported by a Physician from FRANCE on July 06, 2007. Male patient, 62 years of age, was diagnosed with chondritis and was treated with Mabthera. After drug was administered, patient experienced the following side effects: influenza, septic shock. Mabthera dosage: 375 MG/M2, UNK. During the same period patient was treated with CORTICOSTEROID. Patient was hospitalized. Patient died.
Mabthera Side Effects Report #5281132-5
Mabthera side effect was reported by a Physician from BELGIUM on Mar 12, 2007. Female patient, 64 years of age, was diagnosed with b-cell lymphoma and was treated with Mabthera. After drug was administered, patient experienced the following side effects: septic shock. Mabthera dosage: 573.8 MG, INTRAVENOUS. During the same period patient was treated with CYCLOPHOSPHAMIDE, ONCOVIN, DOXORUBICIN, PREDNISONE. Patient died on 10/07/2005.
Mabthera Side Effects Report #5078667-7
Mabthera side effect was reported by a Physician from SPAIN on July 28, 2006. Male patient, 58 years of age, weighting 125.7 lb, was diagnosed with b-cell lymphoma and was treated with Mabthera. After drug was administered, patient experienced the following side effects: cardio-respiratory arrest, neutropenia, pneumonia
, septic shock. Mabthera dosage: 633 MG, INTRAVENOUS. Patient died on 07/25/2006.Mabthera Side Effects Report #5087210-8
Mabthera side effect was reported by a Health Professional from SPAIN on Aug 10, 2006. Male patient, 58 years of age, weighting 125.7 lb, was diagnosed with b-cell lymphoma and was treated with Mabthera. After drug was administered, patient experienced the following side effects: cardio-respiratory arrest, electromechanical dissociation, neutropenia, pneumonia
, septic shock. Mabthera dosage: 633 MG, INTRAVENOUS. During the same period patient was treated with FLUDARABINE PHOSPHATE, CYCLOPHOSPHAMIDE, MITOXANTRONE. Patient died on 07/25/2006.Mabthera Side Effects Report #4759269-6
Mabthera side effect was reported by a Health Professional from FRANCE on Aug 17, 2005. Female patient, 48 years of age, was diagnosed with b-cell lymphoma and was treated with Mabthera. After drug was administered, patient experienced the following side effects: aplasia, cardio-respiratory arrest, septic shock, tachyarrhythmia. Mabthera dosage: 750 MG ; 690 MG. During the same period patient was treated with IFOSFAMIDE, CARBOPLATIN, ETOPOSIDE. Patient died on 08/16/2005.
Mabthera Side Effects Report #4761078-9
Mabthera side effect was reported by a Physician from FRANCE on Aug 17, 2005. Female patient, 48 years of age, was diagnosed with b-cell lymphoma and was treated with Mabthera. After drug was administered, patient experienced the following side effects: aplasia, cardio-respiratory arrest, septic shock, tachyarrhythmia. Mabthera dosage: unknown. During the same period patient was treated with IFOSFAMIDE, CARBOPLATIN, ETOPOSIDE. Patient died on 08/16/2005.
Mabthera Side Effects Report #4799331-5
Mabthera side effect was reported by a Physician from FRANCE on Sept 28, 2005. Female patient, 48 years of age, was diagnosed with b-cell lymphoma and was treated with Mabthera. After drug was administered, patient experienced the following side effects: aplasia, cardio-respiratory arrest, septic shock, tachyarrhythmia. Mabthera dosage: unknown. During the same period patient was treated with IFOSFAMIDE, CARBOPLATIN, ETOPOSIDE. Patient died on 08/16/2005.
Mabthera Side Effects Report #4703419-4
Mabthera side effect was reported by a Physician from on June 14, 2005. Female patient, 37 years of age, was diagnosed with b-cell lymphoma and was treated with Mabthera. After drug was administered, patient experienced the following side effects: escherichia sepsis, septic shock. Mabthera dosage: 700 MG, INTRAVNEOUS. During the same period patient was treated with CYCLOPHOSPHAMIDE. Patient died.
Mabthera Side Effects Report #5357324-3
Mabthera side effect was reported by a Physician from UNITED STATES on June 06, 2007. Male patient was diagnosed with b-cell lymphoma and was treated with Mabthera. After drug was administered, patient experienced the following side effects: septic shock. Mabthera dosage: 375 MG/M2, UNK. During the same period patient was treated with ENZASTAURIN, GEMCITABINE, OXALIPLATIN, GRANOCYTE, LOVENOX, ACUPAN, LASIX. Patient died on 06/02/2007.
Mabthera Side Effects Report #5685168-1
Mabthera side effect was reported by a Physician from GREECE on Mar 20, 2008. Female patient, 74 years of age, was diagnosed with anaemia haemolytic autoimmune, aplasia pure red cell, granulocytopenia and was treated with Mabthera. After drug was administered, patient experienced the following side effects: aplasia pure red cell, corynebacterium sepsis, septic shock. Mabthera dosage: 375 MG/M2, UNK. During the same period patient was treated with NEUPOGEN, PREDNISONE, IMMUNE GLOBULIN, CYCLOPHOSPHAMIDE, RED BLOOD CELLS. Patient died.
Mabthera Side Effects Report #5888619-2
Mabthera side effect was reported by a Consumer or non-health professional from FRANCE on Sept 11, 2008. Male patient, 72 years of age, was diagnosed with anaemia haemolytic autoimmune and was treated with Mabthera. After drug was administered, patient experienced the following side effects: haemolysis, pneumocystis jiroveci pneumonia, septic shock. Mabthera dosage: unknown. Patient died.
Mabthera Side Effects Report #5710468-6
Mabthera side effect was reported by a Physician from UNITED KINGDOM on Apr 08, 2008. Female patient was diagnosed with anaemia haemolytic autoimmune and was treated with Mabthera. After drug was administered, patient experienced the following side effects: agranulocytosis, infection
, septic shock. Mabthera dosage: unknown. Patient was hospitalized. Patient recovered.Mabthera Side Effects Report #5713620-9
Mabthera side effect was reported by a Physician from UNITED KINGDOM on Apr 10, 2008. Female patient was diagnosed with anaemia haemolytic autoimmune and was treated with Mabthera. After drug was administered, patient experienced the following side effects: acute respiratory distress syndrome, agranulocytosis, candidiasis, infection
, septic shock. Mabthera dosage: unknown. Patient was hospitalized. Patient recovered.Mabthera Side Effects Report #5725713-0
Mabthera side effect was reported by a Physician from UNITED KINGDOM on Apr 23, 2008. Female patient was diagnosed with anaemia haemolytic autoimmune and was treated with Mabthera. After drug was administered, patient experienced the following side effects: agranulocytosis, infection
, septic shock. Mabthera dosage: unknown. Patient was hospitalized. Patient recovered.Mabthera Side Effects Report #4704422-0
Mabthera side effect was reported by a Health Professional from on June 10, 2005. Female patient, 82 years of age, was treated with Mabthera. After drug was administered, patient experienced the following side effects: aplastic anaemia, bone marrow depression, septic shock. Mabthera dosage: unknown. During the same period patient was treated with CYCLOPHOSPHAMIDE, FLUDAR, PLENDIL, DIFLUCAN, OMEPRAZOLE, EUSAPRIM, AZACTAM, VANCOMYCIN. Patient died on 02/14/2005.
Mabthera Side Effects Report #4718911-6
Mabthera side effect was reported by a Health Professional from SWEDEN on July 13, 2005. Female patient, 82 years of age, was treated with Mabthera. After drug was administered, patient experienced the following side effects: aplastic anaemia, bone marrow depression, pancytopenia, septic shock. Mabthera dosage: unknown. During the same period patient was treated with CYCLOPHOSPHAMIDE, FLUDARA, PLENDIL, DIFLUCAN, OMEPRAZOLE, TRIMETHOPRIM, AZACTAM, VANCOMYCIN. Patient died on 02/14/2005.
Mabthera Side Effects Report #5205264-2
Mabthera side effect was reported by a Health Professional from GERMANY on Dec 27, 2006. Female patient, 79 years of age, weighting 125.7 lb, was treated with Mabthera. After drug was administered, patient experienced the following side effects: bacterial infection
, joint swelling, oedema peripheral, pulmonary embolism
, sepsis
, septic shock. Mabthera dosage: 375 MG, Q4W, INTRAVENOUS. During the same period patient was treated with ASPIRIN, ENALAPRIL MALEATE, SIMVASTATIN, CARBAMAZEPINE, TOREM, DAFALGAN, ENOXAPARIN, ACTRAPID. Patient died.Mabthera Side Effects Report #4874985-3
Mabthera side effect was reported by a Health Professional from AUSTRALIA on Dec 19, 2005. Female patient, 72 years of age, was treated with Mabthera. After drug was administered, patient experienced the following side effects: agranulocytosis, septic shock, white blood cell count decreased. Mabthera dosage: unknown. During the same period patient was treated with CYCLOPHOSPHAMIDE, VINCRISTINE, PREDNISONE, NEULASTA. Patient recovered.
Mabthera Side Effects Report #4928204-X
Mabthera side effect was reported by a Health Professional from AUSTRALIA on Feb 13, 2006. Female patient, 72 years of age, was treated with Mabthera. After drug was administered, patient experienced the following side effects: agranulocytosis, septic shock, white blood cell count decreased. Mabthera dosage: unknown. During the same period patient was treated with CYCLOPHOSPHAMIDE, VINCRISTINE, PEGFILGRASTIM, PREDNISONE. Patient was hospitalized. Patient recovered.
Mabthera Side Effects Report #6131829-X
Mabthera side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Mar 10, 2009. Male patient, 18 years of age, was treated with Mabthera. After drug was administered, patient experienced the following side effects: bronchopneumonia, cranial neuropathy, septic shock. Mabthera dosage: unknown. During the same period patient was treated with CYCLOPHOSPHAMIDE, DOXORUBICIN, VINCRISTINE, PREDNISONE. Patient died on 02/04/2009.
Mabthera and septic shock 